Literature DB >> 31088816

Severe peripheral oedema as the only presenting symptom of intravascular large B-cell lymphoma: a diagnosis too frequently made on autopsy.

Rachel Kyle1, Gillian Mount2, Shao Shi Li3, Jenny Thain1.   

Abstract

Intravascular large B-cell lymphoma is seen in less than one per million people and can be an extremely difficult antemortem diagnosis to make due to a vast diversity of presenting symptoms. We present a case of an otherwise healthy 74-year-old woman whose predominant symptom was pitting oedema, and who likely died from multiorgan failure after >14 months of extensive workup that was unable to secure a definitive diagnosis. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  geriatric medicine; malignant and benign haematology; pathology

Mesh:

Year:  2019        PMID: 31088816      PMCID: PMC6536203          DOI: 10.1136/bcr-2018-228802

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  [On the recognition of systematized endotheliomatosis of the cutaneous blood vessels (reticuloendotheliosis?].

Authors:  L PFLEGER; J TAPPEINER
Journal:  Hautarzt       Date:  1959-08       Impact factor: 0.751

Review 2.  Intravascular lymphoma: a neoplasm of 'homeless' lymphocytes?

Authors:  Maurilio Ponzoni; Andrés J M Ferreri
Journal:  Hematol Oncol       Date:  2006-09       Impact factor: 5.271

3.  A 69-year-old male presenting with hypotension and anasarca.

Authors:  David M Zlotnick; Edward J Merrens; Elizabeth L Fingar; Norman B Levy
Journal:  Am J Hematol       Date:  2008-04       Impact factor: 10.047

4.  Intravascular large B-cell lymphoma presenting with anasarca-type edema and acute renal failure.

Authors:  Serap Gunes Bilgili; Deniz Yılmaz; Yasemin Usul Soyoral; Ayse Serap Karadag; Irfan Bayram
Journal:  Ren Fail       Date:  2013-07-26       Impact factor: 2.606

Review 5.  Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks.

Authors:  Maurilio Ponzoni; Elias Campo; Shigeo Nakamura
Journal:  Blood       Date:  2018-08-15       Impact factor: 22.113

6.  Intravascular Lymphoma: A Diagnostic Challenge.

Authors:  Emanuel Jose Saad; Diego De Goycoechea; Maria Kurpis; Ricardo Arturo Albertini
Journal:  Conn Med       Date:  2017-05

Review 7.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

Review 8.  Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'.

Authors:  Andrés J M Ferreri; Elías Campo; John F Seymour; Rein Willemze; Fiorella Ilariucci; Achille Ambrosetti; Emanuele Zucca; Giuseppe Rossi; Armando López-Guillermo; Miguel A Pavlovsky; Marie-Louise Geerts; Anna Candoni; Maurizio Lestani; Silvia Asioli; Mario Milani; Miguel A Piris; Stefano Pileri; Fabio Facchetti; Franco Cavalli; Maurilio Ponzoni
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

Review 9.  Angiotropic large cell lymphoma (ALCL): morphological, immunohistochemical and genotypic studies with analysis of previous reports.

Authors:  P Domizio; P A Hall; F Cotter; S Amiel; J Tucker; G M Besser; D A Levison
Journal:  Hematol Oncol       Date:  1989 May-Jun       Impact factor: 5.271

10.  A Case of De Novo CD5+ Disseminated Intravascular Large B-Cell Lymphoma Presenting as Multiorgan Failure.

Authors:  Daulath Singh; Devika Kapuria; Suparna Nanua; Rakesh Gaur
Journal:  Case Rep Hematol       Date:  2016-09-29
View more
  1 in total

1.  Case Report: Intravascular Large B-Cell Lymphoma: A Clinicopathologic Study of Four Cases With Review of Additional 331 Cases in the Literature.

Authors:  Yingying Han; Qingjiao Li; Dan Wang; Lushan Peng; Tao Huang; Chunlin Ou; Keda Yang; Junpu Wang
Journal:  Front Oncol       Date:  2022-05-13       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.